Insider · CIK 0001261869
Margaret B Pyle
Files at KEQU (KEWAUNEE SCIENTIFIC CORP /DE/). First filing -, latest -.
Margaret B Pyle files SEC Form 4 as director at KEQU (KEWAUNEE SCIENTIFIC CORP /DE/). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Margaret B Pyle has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 4 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Mar 26, 2026 | KEQU KEWAUNEE SCIENTIFIC CORP /DE/ | GGift Common Stockindirect: By Trust | -2,750 | $0.00 | $0 | 36,891 | Mar 27, 2026 |
| Jul 29, 2025 | KEQU KEWAUNEE SCIENTIFIC CORP /DE/ | GGift Common Stockindirect: By Trust | -325 | $0.00 | $0 | 39,641 | Jul 30, 2025 |
| May 7, 2025 | KEQU KEWAUNEE SCIENTIFIC CORP /DE/ | AGrant or award Common Stock | +1,896 | $0.00 | $0 | 1,896 | May 9, 2025 |
| Mar 6, 2025 | KEQU KEWAUNEE SCIENTIFIC CORP /DE/ | GGift Common Stockindirect: By Trust | -740 | $0.00 | $0 | 38,070 | Mar 10, 2025 |
Questions about Margaret B Pyle
Answered from the filings on this page, as of the latest one.
Is Margaret B Pyle buying or selling?
Margaret B Pyle has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Margaret B Pyle's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Margaret B Pyle has 0.
Where does Margaret B Pyle file Form 4?
Margaret B Pyle has filed Form 4 at KEQU (KEWAUNEE SCIENTIFIC CORP /DE/). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.